Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-12-28Observational Study of Genetic Predictors of Efficiency and Safety of Immune Checkpoints Inhibitors in Patients With Different Malignancies (ICIPRESIST-0519)
-
CLINICAL_TRIALS study record update · 2021-12-09Induction of Antitumor Response in Melanoma Patients Using the Antimicrobial Peptide LL37
-
CLINICAL_TRIALS study record update · 2021-12-01A Randomized, Single-center, Open-label, Single Dose, Two-period, Crossover Study to Investigate the Relative Bioavailability of Binimetinib 3 x15 mg and 45 mg Tablets in Healthy Participants
-
CLINICAL_TRIALS study record update · 2021-11-23Targeted Melanoma Detection With Skin Self-examination: Leveraging the Mammogram Encounter
-
CLINICAL_TRIALS study record update · 2021-11-22FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-11-16A Phase II, Open-Label, Multicenter, Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients With Malignant Melanoma Pre-Treated With Recombinant CDX-301, a Recombinant Human Flt3 Ligand
-
CLINICAL_TRIALS study record update · 2021-11-15A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCAGN02390 in Participants With Select Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2021-11-11Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
-
CLINICAL_TRIALS study record update · 2021-11-10Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential Future Therapy
-
CLINICAL_TRIALS study record update · 2021-11-04A Phase II Study Exploring the Safety, Tolerability and Preliminary Anti-tumor Activity of Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-29A Phase I/II Trial of Vemurafenib and Metformin to Unresectable Stage IIIC and Stage IV BRAF.V600E+ Melanoma Patients
-
CLINICAL_TRIALS study record update · 2021-10-28Perioperative Encorafinib+Binimetinib in BRAFV600 Mutant Clinically Detected AJCC Stage III (B/C/D) or Oligometastatic Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-26A Randomized Trial Evaluating the Use of Fibrin Tissue Adhesive Following Axillary Node Dissection in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-22PRAME Immunohistochemistry as an Adjunct for Evaluating Ambiguous Melanocytic Proliferation
-
CLINICAL_TRIALS study record update · 2021-10-18A Phase 1 Study of TRAIL-DR5 Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Unresectable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-06Phase II Randomized, Parallel-Group Trial on PTK-ZK With or Without DTIC in Patients With Non-resectable Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-05A Multi-Center Phase 2 Open-Label Study to Evaluate Safety and Efficacy in Subjects With Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy
-
CLINICAL_TRIALS study record update · 2021-09-30Feasibility Study of Biomarker-driven Therapy Based on a Comprehensive Molecular Analysis of Tumor Tissue and Blood Collections in Melanoma
-
CLINICAL_TRIALS study record update · 2021-09-29Open Label Multicenter Phase I/II Study of the Safety and Efficacy of PDR001 Administered to Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2021-09-20Myeloid and Plasmacytoid Blood Dendritic Cells for Immunotherapy of Stage III Melanoma Patients
-
CLINICAL_TRIALS study record update · 2021-09-16Neoadjuvant Phase II Study of TLR9 Agonist CMP-001 in Combination With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease
-
CLINICAL_TRIALS study record update · 2021-09-14An Observational Study in Patients Receiving Adjuvant Nivolumab Therapy for Resected Melanoma
-
CLINICAL_TRIALS study record update · 2021-09-14Two-years Follow-up of Melanoma Patients Treated by Nivolumab During the French ATU Program
-
CLINICAL_TRIALS study record update · 2021-08-24A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Recombinant Humanized Monoclonal Antibody Specific to B- and T- Lymphocyte Attenuator, BTLA (JS004) Injection in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-08-17A Phase II Study of Concurrent Dabrafenib and Trametinib With Stereotactic Radiation in the Management of Patients With BRAF Mutation-Positive Malignant Melanoma and Brain Metastases